Wedbush Morgan reiterates a 'Buy' on Gilead Sciences (Nasdaq: GILD). Price target increased from $56 to $58.

Wedbush ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE